Αρχειοθήκη ιστολογίου

Δευτέρα 12 Ιουνίου 2017

A phase I study of olaparib in addition to cisplatin-based concurrent chemoradiotherapy for patients with high risk locally advanced squamous cell carcinoma of the head and neck (HNSCC)

Forster, M; Mendes, R; Harrington, K; Guerrero-Urbano, T; Baines, H; Spanswick, V; Ensell, L; Forster, M; Mendes, R; Harrington, K; Guerrero-Urbano, T; Baines, H; Spanswick, V; Ensell, L; Hartley, J; Adeleke, S; Gougis, P; Leader, D; Lopes, A; Teague, J; Forsyth, S; Beare, S; - view fewer (2016) A phase I study of olaparib in addition to cisplatin-based concurrent chemoradiotherapy for patients with high risk locally advanced squamous cell carcinoma of the head and neck (HNSCC). Presented at: 2016 ASCO Annual Meeting, Chicago, IL, USA. Green open access

from ! Medicine by Alexandros G. Sfakianakis via als.fakia on Inoreader http://ift.tt/2rRy8DA
via IFTTT

στις

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Εγγραφή σε: Σχόλια ανάρτησης (Atom)

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader

Φόρτωση...